Beyond Air swaps NeuroNOS control for 19.99% UNIVO stake, up to $32.5M in milestones
What's the deal? Beyond Air (NASDAQ: XAIR) has signed a definitive agreement to sell its controlling stake in NeuroNOS IsraelDealroom has a profile for this one. Try Dealroom →, a neurology-focused biopharma, to UNIVO Pharmaceutical IndustriesDealroom has a profile for this one. Try Dealroom → (TASE: UNVO). Beyond Air currently holds 5,000,000 NeuroNOS shares, about 58% of the company on a fully diluted basis, through its wholly owned subsidiary NeuroNOS Limited.
What are the terms? At closing, UNIVO buys Beyond Air's entire NeuroNOS stake. In exchange, Beyond Air receives UNIVO ordinary shares equal to 19.99% of UNIVO's issued and outstanding share capital, plus warrants for another 19.99% of UNIVO's total outstanding options and awards, exercisable at $0.01 per share for five years.
A separate intellectual property agreement transfers certain NeuroNOS-related IP and assets to NeuroNOS. In return, Beyond Air can earn up to $6.5 million in cash development milestones and up to $26.0 million in commercial milestones tied to net sales thresholds — up to $32.5 million in total.
What's the endgame? The deal converts Beyond Air's majority NeuroNOS position into liquid equity in a listed company, UNIVO, alongside potential milestone income. Beyond Air gives up control of NeuroNOS but keeps upside through its stake, warrants, and payments linked to the programs' progress.
What could go wrong? The $32.5 million in milestones is contingent, not guaranteed. Closing depends on board, shareholder, regulatory, and stock exchange approvals, completion of a related investment, and other customary conditions.
The signal: The transaction shows a smaller biopharma monetising a controlling asset without an upfront cash sale, instead taking equity and performance-based payments. For Beyond Air, it swaps operational control for a passive position and a longer-term bet on UNIVO's clinical and commercial success.
Read more: stocktitan.net
Image credit: Generated with Gemini
